docetaxel + mitoxantrone + vinorelbine + cisplatin

This combination brings together four chemotherapeutic agents: **docetaxel**, a taxane that inhibits cell division by stabilizing microtubules; **mitoxantrone**, an anthracenedione that intercalates DNA, disrupting DNA replication and transcription; **vinorelbine**, a vinca alkaloid that disrupts microtubule dynamics; and **cisplatin**, a platinum-based drug that forms DNA crosslinks, triggering apoptosis. Each drug targets cancer cells through different mechanisms, potentially enhancing antitumor activity. However, the specific use of this combination in clinical settings is not detailed in the provided sources.